![]() |
市场调查报告书
商品编码
1876148
婴儿配方奶粉原料及产品市场规模、占有率、成长及全球产业分析:依类型、应用和地区划分的洞察与预测(2024-2032 年)Infant Formula Ingredients and Products Market Size, Share, Growth and Global Industry Analysis By Type & Application, Regional Insights and Forecast to 2024-2032 |
||||||
受婴儿营养意识的提高、女性劳动参与率的上升以及配方奶粉配方技术进步的推动,全球婴儿配方奶粉原料及产品市场持续稳步增长。根据 Fortune Business Insights 预测,该市场规模预计将在 2024 年达到 749.4 亿美元,并在 2025 年达到 776.4 亿美元。预计到 2032 年,该市场将进一步成长至 1,097 亿美元,在预测期(2025-2032 年)内,复合年增长率 (CAGR) 为 5.06%。亚太地区将在 2024 年引领全球市场,占 66.2% 的市场占有率,市场估值达 496.1 亿美元。这反映了该地区强大的消费群体以及人们对婴幼儿健康和保健日益增长的关注。
婴儿配方奶粉旨在取代母乳,透过蛋白质、碳水化合物、脂肪、维生素和矿物质等关键成分提供均衡营养。这些配方奶粉通常以牛奶为基础,但也可用大豆、羊奶和其他植物性成分製成。雀巢、雅培、达能和利洁时集团等全球性公司推动着这个市场的发展,它们不断推出先进产品,以满足具有不同饮食和医疗需求的婴幼儿。
市场动态
市场推动因素-父母意识的提高与对特殊婴儿配方奶粉需求的成长
父母对婴幼儿营养重要性的认识不断提高,显着推动了对与母乳成分高度相似的科学配方产品的需求。在亚洲、中东和北美,越来越注重健康的父母正在寻找富含人乳低聚醣 (HMO)、益生元和乳铁蛋白的配方奶粉,以支持婴儿的免疫和消化健康。
对特殊婴儿配方奶粉的需求是另一个主要的成长因素。随着婴儿乳糖不耐症和食物过敏的盛行率不断上升,製造商正在推出创新的无乳糖、低过敏性和植物性产品。例如,2024 年 9 月,Perrigo 与 Dr. Brown's 和 GoodStart 合作推出了一款 100% 植物性、无乳糖的婴儿配方奶粉,该产品在美国主要零售商(如沃尔玛、克罗格和亚马逊)有售。这些专业解决方案为过敏和不耐受的婴儿提供支持,推动了全球市场的扩张。
市场阻碍因素-高昂的製造成本和原物料价格波动
儘管需求强劲,但采购优质婴儿配方奶粉原料(例如奶粉、植物油和维生素)的高昂製造成本构成了一项重大挑战。价格波动,尤其是有机原料和特殊原料的价格波动,以及供应链中断和能源成本上涨,都在影响生产利润率。
市场机会-配方奶粉研发的技术创新
技术进步正在为市场扩张开闢新的途径。先进的生产技术,例如微滤、超临界流体萃取和基于发酵的合成,使得生产更接近母乳特性的原料成为可能。例如,2020年4月,康纳根公司(Conagen Inc.)利用发酵技术开发出乳铁蛋白,这是一种对婴儿免疫力至关重要的蛋白质,从而减少了对传统乳製品原料的依赖,并降低了生产成本。
市场趋势
消费者对模拟母乳成分的新偏好
消费者越来越倾向于选择添加了模拟母乳营养结构的成分的婴儿配方奶粉。诸如OPO(结构性脂质)、HMO和A2 β-酪蛋白等成分正受到越来越多的关注,尤其是在中国、印度和东南亚地区。 2023年10月,国际香料香精公司(IFF)、帝斯曼-菲美尼克公司和蒙牛公司在中国获得监管部门批准,可在婴儿配方奶粉生产中使用HMO和益生菌,这标誌着婴儿配方奶粉正朝着高品质、生物活性更高的配方方向发展。
依成分类型划分:
2024年,碳水化合物作为婴儿的主要能量来源,占了全球婴儿配方奶粉成分市场的最大占有率。乳糖是大多数婴儿配方奶粉的必要成分,因为它有助于大脑发育和营养吸收。脂肪占婴儿热量摄取的40-45%,并促进神经系统发育,占了第二大占有率。蛋白质对组织生长和修復至关重要,占了第三大占有率。益生元和益生菌区隔市场预计将在2032年之前实现最快成长,这得益于针对肠道健康和免疫健康的持续创新。
依产品类型划分:
2024年,针对特定营养需求(例如过敏、代谢紊乱和早产儿营养)的特製婴儿配方奶粉区隔市场引领市场。由于其成分与天然母乳相似,且对婴儿的免疫系统和消化系统有益,富含人乳低聚醣(HMO)的婴儿配方奶粉是增长最快的品类。 2023年3月,达能公司在美国推出了Pepticate,这是一款专为牛奶蛋白过敏婴儿设计的低致敏性水解配方奶粉。
亚太地区 - 2024年主要市场
亚太地区预计将主导市场,到2024年市场规模将达到496.1亿美元,这主要得益于女性劳动参与率的提高、快速的城市化进程以及中产阶级的壮大。中国、印度和印尼等国家对高品质的专业婴幼儿营养产品需求强劲。中国的二孩政策改革也刺激了出生率的上升,并增加了产品消费。据世界银行称,女性劳动参与率的提高可使该地区的GDP成长51%,间接推动婴儿配方奶粉市场的发展。
北美:
继2022年美国婴儿配方奶粉短缺之后,製造商正在加强本地供应链并制定安全法规,以确保产品供应稳定。国内生产和政府干预继续支持该地区的復苏和供应稳定。
欧洲:
欧洲消费者强烈偏好有机和无添加剂的婴儿配方奶粉,基于母乳寡糖 (HMO) 和 A2 蛋白的产品越来越受欢迎。针对乳糖不耐症和过敏管理的优质产品正在推动该地区的稳定成长。
南美洲:
该地区稳定的出生率和不断增长的可支配收入正在推动对功能性植物基大豆婴儿配方奶粉的需求。巴西和阿根廷的製造商正在以 "支持骨骼健康" 和 "温和不刺激肠胃" 等宣传语来定位其产品,以吸引註重健康的父母。
中东和非洲:
不断增长的外籍人口和对优质进口婴儿配方奶粉的需求正在推动市场扩张,尤其是在阿拉伯联合大公国和沙乌地阿拉伯。
The global infant formula ingredients and products market continues to grow steadily, driven by increasing awareness of infant nutrition, rising female workforce participation, and technological advancements in formula composition. According to Fortune Business Insights, the market was valued at USD 74.94 billion in 2024, is projected to reach USD 77.64 billion in 2025, and is estimated to expand to USD 109.70 billion by 2032, reflecting a CAGR of 5.06% during the forecast period (2025-2032). Asia Pacific dominated the global landscape in 2024, accounting for 66.2% of the market share, with a valuation of USD 49.61 billion, underscoring the region's strong consumer base and growing focus on infant health and wellness.
Infant formula products are designed to serve as alternatives to breast milk, providing balanced nutrition through key ingredients such as proteins, carbohydrates, fats, vitamins, and minerals. These formulas are often derived from cow's milk but can also be sourced from soy, goat milk, and other plant-based materials. The market is being driven by global players like Nestle S.A., Abbott, Danone S.A., and Reckitt Benckiser Group plc, who continue to introduce advanced products catering to infants with diverse dietary and medical needs.
Market Dynamics
Market Drivers - Growing Parental Awareness and Demand for Specialized Formulas
Rising parental awareness about the importance of infant nutrition has significantly fueled the demand for scientifically formulated products that closely resemble human milk. Increasingly health-conscious parents in Asia, the Middle East, and North America are seeking formulas enriched with HMOs (Human Milk Oligosaccharides), prebiotics, and Lactoferrin, which support immunity and digestive health.
The demand for specialty infant formulas is another key growth driver. As the prevalence of lactose intolerance and food allergies among infants rises, manufacturers are launching innovative lactose-free, hypoallergenic, and plant-based products. For instance, in September 2024, Perrigo Company plc partnered with Dr. Brown's Company and Good Start to introduce a 100% plant-based, lactose-free infant formula available through major U.S. retailers such as Walmart, Kroger, and Amazon. These specialized solutions help infants with allergies or sensitivities, supporting market expansion worldwide.
Market Restraints - High Production Costs and Ingredient Price Volatility
Despite strong demand, the high manufacturing costs of infant formula ingredients-driven by the procurement of high-quality milk powder, vegetable oils, and vitamins-pose a significant challenge. Price fluctuations in raw materials, especially organic and specialty components, combined with supply chain disruptions and energy cost increases, have impacted production margins.
Market Opportunities - Technological Innovations in Formula Development
Technological advancements have opened new avenues for market expansion. Cutting-edge production techniques such as microfiltration, supercritical fluid extraction, and fermentation-based synthesis are enabling the creation of ingredients that mimic human milk properties more closely than ever before. For example, in April 2020, Conagen Inc. developed Lactoferrin-a key protein for infant immunity-using fermentation technology, reducing dependence on traditional dairy sources and lowering production costs.
Market Trends
Emerging Preference for Human-Milk-Mimicking Ingredients
Consumers increasingly favor infant formulas enriched with components that replicate the nutritional structure of human milk. Ingredients such as OPO (Structured Lipids), HMOs, and A2 B-casein proteins are gaining traction, particularly in China, India, and Southeast Asia. In October 2023, International Flavors & Fragrances (IFF), DSM-Firmenich, and Mengniu received regulatory approval to use HMOs and probiotics in infant formula production in China, signaling a shift toward premium, biologically advanced formulations.
By Ingredient Type:
In 2024, carbohydrates held the largest share of the global infant formula ingredients market, as they serve as the primary energy source for infants. Lactose supports brain development and nutrient absorption, making it an essential component in most formulas. Fats accounted for the second-largest share, contributing 40-45% of infants' caloric intake and promoting nervous system development. Proteins, crucial for tissue growth and repair, held the third-largest share. The prebiotics and probiotics segment is projected to grow the fastest through 2032, supported by ongoing innovations targeting gut and immune health.
By Product Type:
The specialty formula segment dominated the market in 2024, addressing specific dietary needs such as allergies, metabolic disorders, and premature birth nutrition. The HMO-enriched formula segment represents the fastest-growing category, driven by its similarity to natural breast milk composition and its ability to enhance infants' immune and digestive systems. In March 2023, Danone launched Pepticate, a hypoallergenic hydrolyzed powdered formula in the U.S., to cater to infants with cow's milk allergies.
Asia Pacific - The Leading Market in 2024
Asia Pacific held the dominant share with a market value of USD 49.61 billion in 2024, driven by increasing female workforce participation, rapid urbanization, and expanding middle-class populations. Countries such as China, India, and Indonesia are witnessing a strong demand for premium and specialized infant nutrition products. The Chinese government's two-child policy reform has also stimulated birth rates, leading to higher product consumption. According to the World Bank, increasing women's workforce participation could enhance the region's GDP by 51%, indirectly boosting the infant formula market.
North America:
Following the 2022 infant formula shortage in the U.S., manufacturers are strengthening local supply chains and safety regulations to ensure product stability. Domestic production and government intervention continue to shape the region's recovery and supply consistency.
Europe:
European consumers show a strong inclination toward organic and additive-free formulas, with growing adoption of HMO- and A2-protein-based products. Premium offerings targeting lactose intolerance and allergy management are driving steady regional growth.
South America:
The region's stable birth rates and rising disposable incomes are fueling demand for functional, plant-based soy formulas. Manufacturers in Brazil and Argentina are focusing on positioning their products with claims such as "supports bone health" and "gentle on the stomach" to attract health-conscious parents.
Middle East & Africa:
The increasing expatriate population and demand for premium imported infant formulas are contributing to market expansion, especially in the United Arab Emirates and Saudi Arabia.
Competitive Landscape
The market features strong competition among leading companies such as Nestle S.A. (Switzerland), Abbott (U.S.), Danone S.A. (France), Reckitt Benckiser Group plc (U.K.), and Junlebao Dairy Group (China). Other notable players include Fonterra Co-operative Group Limited, DSM-Firmenich, Cargill, Inc., Almarai, and FrieslandCampina N.V.
Recent Industry Developments:
Conclusion
The global infant formula ingredients and products market is set to expand from USD 74.94 billion in 2024 to USD 109.70 billion by 2032, reflecting sustained growth across all regions. Rising consumer awareness, technological innovation, and premiumization trends are reshaping the infant nutrition industry. With Asia Pacific leading the charge and Western markets focusing on safety, sustainability, and advanced formulations, the sector is poised to achieve strong, innovation-driven growth throughout the 2025-2032 period.
Segmentation By Ingredient Type
By Product Type
By Region